BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 8174966)

  • 1. Erythromycin induces supranormal gall bladder contraction in diabetic autonomic neuropathy.
    Catnach SM; Ballinger AB; Stevens M; Fairclough PD; Trembath RC; Drury PL; Watkins PJ
    Gut; 1993 Aug; 34(8):1123-7. PubMed ID: 8174966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic autonomic neuropathy causing gall bladder dysfunction.
    Gaur C; Mathur A; Agarwal A; Verma K; Jain R; Swaroop A
    J Assoc Physicians India; 2000 Jun; 48(6):603-5. PubMed ID: 11273539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of erythromycin on gallbladder emptying in diabetic patients with and without autonomic neuropathy and high levels of motilin.
    Fiorucci S; Scionti L; Bosso R; Desando A; Bottini P; Marino C; Morelli A
    Dig Dis Sci; 1992 Nov; 37(11):1671-7. PubMed ID: 1425065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motilin induces gall bladder emptying and antral contractions in the fasted state in humans.
    Luiking YC; Peeters TL; Stolk MF; Nieuwenhuijs VB; Portincasa P; Depoortere I; van Berge Henegouwen GP; Akkermans LM
    Gut; 1998 Jun; 42(6):830-5. PubMed ID: 9691922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral clarithromycin on gall-bladder motility in normal subjects and those with gall-stones.
    Sengupta S; Modak P; McCauley N; O'Donnell LJ
    Aliment Pharmacol Ther; 2006 Jul; 24(1):95-9. PubMed ID: 16803607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of erythromycin on human biliary motility.
    Wehrmann T; Pfeltzer C; Caspary WF
    Aliment Pharmacol Ther; 1996 Jun; 10(3):421-6. PubMed ID: 8791972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gall bladder dysmotility in diabetes mellitus--an ultrasound study.
    Sharma MP; Saraya A; Anand AC; Karmarkar MG
    Trop Gastroenterol; 1995; 16(3):13-8. PubMed ID: 8838037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisapride improves gallbladder emptying in patients with type 2 diabetes mellitus.
    Dhiman RK; Arke L; Bhansali A; Gupta S; Chawla YK
    J Gastroenterol Hepatol; 2001 Sep; 16(9):1044-50. PubMed ID: 11595071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral erythromycin on gallbladder motility in normal subjects and subjects with gallstones.
    Catnach SM; Fairclough PD; Trembath RC; O'Donnell LJ; McLean AM; Law PA; Wickham JE
    Gastroenterology; 1992 Jun; 102(6):2071-6. PubMed ID: 1587426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 5-hydroxytryptamine re-uptake impairs human gall-bladder emptying.
    Gorard DA; Healy JC; O'Donnell LJ; Farthing MJ
    Aliment Pharmacol Ther; 1994 Aug; 8(4):461-4. PubMed ID: 7986972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of erythromycin action on gallbladder motility in patients with non-ulcer dyspepsia].
    Liu YG; Nie YQ; Qian W
    Zhonghua Nei Ke Za Zhi; 1994 Jun; 33(6):376-8. PubMed ID: 7867425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive assessment of gastrointestinal motility disorders in diabetic patients with and without cardiovascular signs of autonomic neuropathy.
    Werth B; Meyer-Wyss B; Spinas GA; Drewe J; Beglinger C
    Gut; 1992 Sep; 33(9):1199-203. PubMed ID: 1427371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: gall-bladder motor function in diabetes mellitus.
    Pazzi P; Scagliarini R; Gamberini S; Pezzoli A
    Aliment Pharmacol Ther; 2000 May; 14 Suppl 2():62-5. PubMed ID: 10903007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent stimulation of gallbladder contraction by intravenous erythromycin in man.
    Catnach SM; Ballinger AB; Law PA; Nellans H; Fairclough PD
    Aliment Pharmacol Ther; 1993 Feb; 7(1):55-9. PubMed ID: 8439638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of octreotide on fasting gall bladder emptying, antroduodenal motility, and motilin release in acromegaly.
    Stolk MF; van Erpecum KJ; Koppeschaar HP; Samsom M; Smout AJ; Akkermans LM; Peeters TL; vanBerge-Henegouwen GP
    Gut; 1995 May; 36(5):755-60. PubMed ID: 7797127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of octreotide on gall stone prevalence and gall bladder motility in acromegaly.
    Catnach SM; Anderson JV; Fairclough PD; Trembath RC; Wilson PA; Parker E; Besser GM; Wass JA
    Gut; 1993 Feb; 34(2):270-3. PubMed ID: 8432484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallbladder motility in diabetes mellitus using real time ultrasonography.
    Hahm JS; Park JY; Park KG; Ahn YH; Lee MH; Park KN
    Am J Gastroenterol; 1996 Nov; 91(11):2391-4. PubMed ID: 8931423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallbladder volume and emptying in diabetics: the role of neuropathy and obesity.
    Palasciano G; Portincasa P; Belfiore A; Baldassarre G; Cignarelli M; Paternostro A; Albano O; Giorgino R
    J Intern Med; 1992 Feb; 231(2):123-7. PubMed ID: 1541933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prokinetic effect of alpha-adrenergic antagonist, and beta-adrenergic antagonist on gall-bladder motility in humans with gall-stone disease.
    Sengupta S; Modak P; McCauley N; O'Donnell LJ
    Eur J Gastroenterol Hepatol; 2007 Jul; 19(7):581-3. PubMed ID: 17556905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between gall bladder fasting volume and postprandial emptying in patients with gall stones and healthy controls.
    Pauletzki J; Cicala M; Holl J; Sauerbruch T; Schafmayer A; Paumgartner G
    Gut; 1993 Oct; 34(10):1443-7. PubMed ID: 8244118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.